Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Clinical data from Lidakol phase III studies

May 24, 1996

Preliminary phase II results for HNK20

May 24, 1996

RSV inhibitors presented by Wyeth-Ayerst

May 24, 1996

Antiinfluenza activity of LY-180299 described at congress

May 24, 1996

BW-1263W94 selected for clinical testing in CMV infection

May 24, 1996

NF-1153 demonstrates potent activity against influenza virus

May 24, 1996

Japanese researchers present anti-RSV agent at congress

May 24, 1996

NF-1062 evaluated for activity against rotavirus

May 24, 1996

Schering-Plough claims antiherpesvirus agents

May 24, 1996

Antifungal activity and good tolerability in phase I trial of L-743872

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...